Prevalence and prognostic impli- cations of coronary artery calcification in low-risk women: a meta- analysis. JAMA. 2016;316:2126 34. S2.2-20. Carr JJ, Jacobs DR Jr, Terry JG, et al. Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death. JAMA Cardiol. 2017;2:391 9. S2.2-21. Mortensen MB, Fuster V, Muntendam P, et al. A simple disease- guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study. J Am Coll Cardiol. 2016;68:881 91. S2.2-22. Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133:849 58. S2.2-23. Patel J, Al Rifai M, Blaha MJ, et al. Coronary artery calcium improves risk assessment in adults with a family history of premature coronary heart disease: results from the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging. 2015;8:e003186. S2.2-24. Pursnani A, Massaro JM, D Agostino RB Sr, et al. Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events. JAMA. 2015;314:134 41. S2.2-25. Valenti V, Hartaigh B, Heo R, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a pro- spective follow-up of 9 715 individuals. JACC Cardiovasc Imaging. 2015;8:900 9. S2.2-26. Yano Y, O Donnell CJ, Kuller L, et al. Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies. JAMA Cardiol. 2017;2:986 94. S2.2-27. Yeboah J, Young R, McClelland RL, et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol. 2016;67:139 47. S2.2-28. Multi-Ethnic Study of Atherosclerosis. MESA 10-Year CHD Risk with Coronary Artery Calcification. Available at: https://www. mesa-nhlbi.org/MESACHDRisk/MesaRiskScore/RiskScore.aspx. Accessed September 21, 2018. S2.2-29. Astronaut Cardiovascular Health and Risk Modification (Astro- CHARM). 